ArticleScientific reports2023

Leveraging a KRAS-based signature to predict the prognosis and drug sensitivity of colon cancer and identifying SPINK4 as a new biomarker.

Jian-Ting Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.